Madoka Yoshimura

Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products

S. Takeda, T. Hijikata, Y. Miyagoe-Suzuki, 2007, Gene Therapy.

Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ.

A. Nakamura, S. Takeda, Y. Shimatsu, 2005, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene.

G. Dickson, S. Takeda, Misao Suzuki, 2002, Biochemical and biophysical research communications.

AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.

S. Takeda, Y. Miyagoe-Suzuki, K. Yuasa, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies

A. Nakamura, S. Takeda, Y. Fujii, 2006, BMC cardiovascular disorders.